EUSA Pharma, a multinational biopharmaceutical company for rare diseases and oncology, recently appointed Carsten Thiel as President Europe while Darrel P. Cohen also became the new Head of Clinical Development. The pedigree of both appointees ensures that things can only get better for the global organization.
Thiel, the new President, was born in Berlin where he spent his youth. He studied chemistry in Malbrook. Thereafter, he left Berlin for UK to attend the University of Bristol where he studied organic chemistry. After receiving his Bachelor of Science degree, he specialized in biochemistry. He later earned his PhD in Molecular Biology from the Max Planck Institute for Biophysical Chemistry.
After his formal education, Thiel cut his professional teeth with Hoffman la-Roche as the communication and product manager. By virtue of his academic excellence, he was able to create a positive reputation with the company soon enough. That definitely led to more responsibilities in the areas of scientific marketing and market assessment.
Thiel is expected to steer the ship with his 27 years’ commercial experience gotten from various positions within the pharmaceutical industry which include being the CEO of Abeona Therapeutics Inc. He has also worked at Alexion Pharmaceuticals Inc., and Amgen.
On the other hand, Darrel P. Cohen’s career has also been enviable. He is a Medical Doctor and he also has a PhD in Microbiology. He brings his 20 years’ clinical development experience to the table. Before the new appointment, he was the Vice President, Clinical Development Leader in Pfizer, a global pharmaceutical organization.
He has also worked at Sanofi-Aventis Oncology and Pharmacia Oncology. He got both his MD and PhD in Microbiology from the Boston University of Medicine, Boston. According to the current CEO of EUSA Pharma, there cannot be a better time for the two pharmaceutical veterans to join the organization especially now that EUSA Pharma is extending its coverage by rolling out several products.
Visit Carsten LinkedIn : https://ch.linkedin.com/in/carsten-thiel-8970b45